Aspartate 2026-11-05
Aspartate denotes an anionic form of aspartic acid. A common biochemical example is the L-configured monoanion, with two carboxylate groups and one positively charged amino group. Its formula is and its net charge is .[ref]
The charge count isHaving both positive and negative groups therefore does not imply a zero total charge. Compared with neutral aspartic acid, formation of this conjugate base removes a proton; it does not change the four-carbon connectivity or, by itself, reverse the L/D stereochemistry.
An illustrative acid–base comparison keeps these questions separate. For one protonation step in a dilute solution, the Henderson-Hasselbalch equation gives . One pH unit above that step's gives a ratio of about ten. This is a symbolic illustration, not a numerical assignment of the molecule's several dissociation constants. Specifying ionic form, pH and stereochemistry is more informative than treating every use of the name aspartate as one context-free structure.
Aspartic acid 2026-11-05
Aspartic acid is an alpha-amino acid with two carboxyl groups, represented in a neutral structural form as . Its molecular formula is . One carboxyl group belongs to the amino-acid backbone and the other terminates the side chain.[ref]
The protein-associated L configuration and the sequence symbols Asp and D are separate naming conventions. A one-letter D in a protein sequence denotes the aspartic-acid residue; it is not a declaration of D stereochemistry.[ref]
Loss or redistribution of protons changes the ionic form. The name aspartate commonly denotes the anionic form. For example, a form with two carboxylates carrying each and an ammonium group carrying has net charge . This charge count must be kept distinct from the L/D configuration and from atom connectivity.
The side-chain carboxyl chemistry also matters in aspartic proteases, where appropriately positioned acidic groups participate in peptide bond hydrolysis. Presence of an aspartic-acid residue alone does not establish catalytic activity: its geometry and chemical environment matter.[ref]
EF hand 2026-11-05
An EF hand is a protein structural motif in which two alpha helices flank a loop. In a canonical calcium-binding EF hand, the loop contains 12 amino acid residues whose oxygen-containing groups organize a calcium ion site. PROSITE identifies coordinating positions 1, 3, 5, 7, 9 and 12; the final glutamate or aspartate can contribute two oxygen atoms. The motif is an arrangement of a chain, not a literal separate hand-shaped molecule.[ref]
EF-hand calcium-binding domain signature and profile in PROSITE. PDOC00018, Description: loop organization and coordinating positions
Structural evidence makes the arrangement concrete. The deposited calmodulin structure PDB 1CLL was determined by X-ray crystallography at resolution. Its model contains four calcium ions and two EF-hand binding loops in each lobe. A resolved ion and surrounding coordinates support a structural binding-site interpretation; they do not by themselves specify the rate or affinity of binding in every solution condition.[ref]
Calmodulin structure 1CLL in the Protein Data Bank. Experimental Data Snapshot and Primary Citation abstract
An original one-site model illustrates the distinction. If a site binds calcium independently with dissociation constant and free calcium concentration , the equilibrium occupied fraction isAt , half the sites are occupied; at , the fraction is . These values follow from the stipulated model and are not affinity measurements for PDB 1CLL.
EF hands commonly occur as interacting pairs, and atypical or altered relatives need not retain the same binding properties.[ref]
EF-hand calcium-binding domain signature and profile in PROSITE. Description: paired motifs, cooperativity and excluded nonbinding/atypical regions
Counting motifs alone therefore cannot justify treating every site as an identical independent binder. Structural arrangement, sequence chemistry and binding measurements provide complementary information. E. Ruoslahti 2026-11-05
E. Ruoslahti coauthored, with M. D. Pierschbacher, a 1984 study showing that a short synthetic peptide could reproduce a measured cell-attachment activity of fibronectin. This connected cell adhesion to a specified part of a protein sequence.[ref]
The tested peptide contained arginine, glycine, aspartate and serine. Finding activity in a defined fragment supplied a way to ask which features of the original fibronectin molecule were needed for that particular interaction.[ref]
An illuminating comparison is between recognition and the complete biological task. A small fragment can retain an attachment signal while lacking the size and other binding regions of the original protein. Localizing a recognition sequence therefore does not reduce every property of the original molecule to that sequence.
M. D. Pierschbacher 2026-11-05
M. D. Pierschbacher coauthored a 1984 experiment localizing a cell-attachment activity of fibronectin to a short peptide. With E. Ruoslahti, M. D. Pierschbacher showed that a synthetic four-residue sequence could reproduce the measured attachment-promoting activity.[ref]
The sequence comprises arginine, glycine, aspartate and serine, often written RGDS. The experimentally tested four-residue peptide should be distinguished from the embedded RGD motif and from the entire fibronectin molecule.[ref]
The experiment converts a broad observation into a molecular question. A large protein can contain many functional regions; a synthetic fragment tests whether one specified sequence is sufficient for a particular assay response. Reproducing that response does not establish that the fragment reproduces every function of fibronectin.